Click a link below to view the mailing archive as if it had been sent to you.
| 2023-12-31 12:15 | | Novo Nordisk submits application for massive manufacturing campus near Dublin and more... |
| 2023-12-28 00:15 | | BMS enters radiopharma race with $4.1B acquisition of RayzeBio just 3 months after biotech went public and more... |
| 2023-12-22 12:15 | | Bristol Myers to acquire brain drug developer Karuna for $14B and more... |
| 2023-12-21 12:15 | | Merck’s Chronic Cough Drug Fails to Secure FDA Approval for Second Time and more... |
| 2023-12-21 00:15 | | Failed Illumina and Sanofi Deals Shine Light on FTC Antitrust Crackdown and more... |
| 2023-12-20 12:15 | | Q&A: JLL Analyst Mark Bruso on Biopharma Venture Capital Activity and more... |
| 2023-12-20 00:15 | | FDA Facing Increased Scrutiny Over Medical Device Recalls and more... |
| 2023-12-19 12:15 | | After a record run, fewer biotechs are going public. Here’s how they’re performing. and more... |
| 2023-12-19 00:15 | | Structure shares sink as obesity pill misses expectations in small study and more... |
| 2023-12-18 12:15 | | Obesity drug Mounjaro to surpass Ozempic with $27 billion sales in 2029 and more... |
| 2023-12-18 00:15 | | Biden, Big Pharma Increasingly at Loggerheads in Run-Up to 2024 Election and more... |
| 2023-12-15 12:15 | | Pfizer Inks Potential $1B ADC Deal with Nona, Closes Seagen Acquisition and more... |
| 2023-12-15 00:15 | | Moderna, Merck Cancer Vaccine-Keytruda Combo Gets Win at Three-Year Mark and more... |
| 2023-12-14 12:15 | | Pharma, Life Sciences Sector to See Healthy M&A Activity in 2024: PwC and more... |
| 2023-12-14 00:15 | | Sanofi pharmaceutical plant found to have leaked neurotoxin in south-western France and more... |
| 2023-12-13 12:15 | | Why heart device makers are investing in left atrial appendage closure and more... |
| 2023-12-13 00:15 | | FTC, in unusual move, leads Sanofi to terminate a drug research deal and more... |
| 2023-12-12 12:15 | | Pfizer reveals reorganization, executive departure as it gets ready to close $43B Seagen buyout and more... |
| 2023-12-12 00:15 | | Lilly Stock Slips as Patients Regain Weight After Stopping Zepbound and more... |
| 2023-12-11 12:15 | | Bluebird’s Newly Approved SCD Gene Therapy Faces Rough Road with Hefty Price Tag, Boxed Warning and more... |
| 2023-12-11 00:15 | | Merck suffers bad week as 3 Keytruda combination trials fail and more... |
| 2023-12-08 12:15 | | In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease and more... |
| 2023-12-08 00:15 | | The Doctor is In(bound): Opening Up Two-Way Communication Doubles Digital Engagement and more... |
| 2023-12-07 12:15 | | US sets policy to seize government-funded drug patents if price deemed too high and more... |
| 2023-12-07 00:15 | | AbbVie to buy Cerevel in $8.7B bet on brain drugs and more... |
| 2023-12-06 12:15 | | Merck KGaA’s BTK Inhibitor Fails Phase III Multiple Sclerosis Studies and more... |
| 2023-12-06 00:15 | | Travere cuts workforce by 20% as Filspari's prospects are up in one rare kidney disease, down in another and more... |
| 2023-12-05 12:15 | | CRISPR eyes autoimmune disease in revamp of cell therapy plans and more... |
| 2023-12-05 00:15 | | Genentech's MS drug on partial hold in US after liver enzyme elevations in 2 patients and more... |
| 2023-12-04 12:15 | | Roche joins obesity drug chase with $2.7B deal for startup Carmot and more... |
| 2023-12-04 00:15 | | Opioid maker Purdue’s bankruptcy case comes before Supreme Court and more... |
| 2023-12-01 12:15 | | GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status and more... |
| 2023-12-01 00:15 | | Pharma’s engagement with healthcare providers has slipped in recent years and more... |
